相关实验视频

Updated: May 21, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

一项关于密码性肝脏脑病查认知在肝病学医疗护理人员之间的定性研究

Xiao-Qin Li¹, Wen Cao¹, Tian-Tian Yin¹

¹Department of Infectious Disease, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, 225300, People's Republic of China.

Journal of multidisciplinary healthcare

|March 20, 2025

概括

肝病学专业人员支持对密码性肝脑病变 (CHE) 的查,但知识差距和工作流程挑战阻碍了实施. 解决这些问题是早期干预和改善患者生活质量的关键.

科学领域:

肝病学肝病学是一种肝病学.
神经科学是一个神经科学.
医疗保健管理的管理

背景情况:

密码性肝脑病变 (CHE) 查对于患者的治疗结果至关重要.
了解医疗保健专业人员的观点对于有效实施至关重要.

研究的目的:

探索肝病学医疗保健专业人员对CHE查的态度和看法.
确定标准化CHE查实施的障碍和促进因素.

主要方法:

使用的现象学研究方法.
与9名肝病学专业人员进行了半结构化的深度访谈.
科拉伊兹的数据分析七步方法.

主要成果:

专业人士对CHE查表现出积极的态度.
确定的障碍包括对CHE和测试工具的知识不足,资源有限,以及患者缺乏合作.
关键主题:知识缺陷,积极的查态度和实际的查挑战.

结论:

肝病学人员对CHE查有利,但需要增强知识和支持.
医院管理人员应解决工作流程障碍,并制定有针对性的战略.
专注于早期CHE检测和管理可以改善生活质量,并防止疾病的进展.

关键词:

认知认知认知密码性肝脏脑病变 - 肝脏脑病变.现象学研究现象学研究

更多相关视频

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

相关概念视频

Esophageal Varices-II: Clinical Features and Management

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.